Senior Director, National Field Access, Endocrinology

Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators. In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease. This role will serve as a key leader within the Market Access organization, developing and executing field access strategies that align with Corcept’s commercial goals. You will collaborate cross-functionally with Sales, Marketing, Patient Services (HUB), Trade & Distribution, Payer & Channel Strategy, Legal, and Compliance teams to identify access barriers and develop field-based solutions to overcome them. This is a high-impact leadership role with a focus on team development, access strategy execution, operational excellence, and cross-functional partnership — all in the service of helping patients start and stay on life-changing therapy. Responsibilities: Team Leadership & Strategy Lead, mentor, and manage the national FRM team, providing strategic direction, coaching, performance feedback, and professional development Define and drive national field access strategy for Korlym and Relacorilant, aligning with overall Market Access and Commercial goals Establish and monitor KPIs, productivity metrics, and business objectives to ensure consistent performance and impact across regions Oversee field deployment, territory alignments, and resource allocation for optimal coverage and efficiency Design, implement, and oversee the FRM team’s MBO (Management by Objectives) plan and incentive compensation structure, ensuring alignment with corporate goals, compliance standards, and individual performance metrics Cross-Functional & External Collaboration Serve as the primary liaison between the FRM team and internal stakeholders including Sales, HUB, Patient Services, Trade, Market Access, Legal, and Compliance Partner with Sales Leadership to align field access strategies with account planning and pull-through efforts Collaborate with Marketing to ensure field teams are aligned on messaging, access tools, and reimbursement support materials Interface with HUB leadership and SP partners to ensure seamless patient support and issue resolution processes Provide strategic insights and feedback to Payer and Trade teams regarding payer policy trends, access barriers, and reimbursement landscape dynamics Operational Excellence Lead regular team meetings, field rides, and best practice sharing forums to maintain alignment, foster collaboration, and drive continuous improvement Review and analyze field intelligence, access data, and patient support trends to identify barriers and proactively develop strategies to address them Develop and manage budgets, travel, and team operations in compliance with company policies Partner with Compliance and Legal to ensure all field access activities meet appropriate guidelines and regulations Preferred Skills, Qualifications and Technical Proficiencies: Proven success leading a national or large regional team of FRMs, Access Specialists, or equivalent roles Deep knowledge of payer policy, reimbursement processes, HUB services, specialty pharmacy distribution, and patient support programs Exceptional leadership and people management skills with a track record of building, developing, and retaining high-performing teams Strong cross-functional collaboration experience, especially with Sales, Marketing, Patient Services, and Trade/Channel partners Excellent communication and interpersonal skills, with the ability to influence and lead across levels and functions Demonstrated ability to translate field insights into strategic access initiatives and pull-through solutions High degree of business acumen, project management, and analytical thinking Ability to travel up to 50%, including field visits, conferences, and internal meetings Preferred Education and Experience: Bachelor’s degree required; advanced degree (MBA, MPH, MHA) preferred 12+ years of experience in pharmaceutical/biotech industry with a minimum of 5 years in reimbursement, market access, or patient services, and 5+ years of direct leadership experience managing field teams Experience in rare disease, endocrinology, or specialty pharma Launch experience is a plus, especially for therapies with complex access pathways #LI-Remote The pay range that the Company reasonably expects to pay for this position is $212,200 - $300,000; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education. Applicants must be currently authorized to work in the United States on a full-time basis. For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link. Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs. Please visit our website at: https://www.corcept.com/ Corcept is an Equal Opportunity Employer Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.